IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIVA, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.305
EU - Europa 8.849
AS - Asia 8.451
SA - Sud America 812
AF - Africa 273
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 18
Totale 27.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.946
CN - Cina 2.551
SG - Singapore 2.522
IT - Italia 2.481
GB - Regno Unito 1.980
DE - Germania 977
HK - Hong Kong 873
RU - Federazione Russa 759
VN - Vietnam 681
SE - Svezia 631
BR - Brasile 606
FR - Francia 468
BD - Bangladesh 392
NL - Olanda 353
IN - India 319
FI - Finlandia 298
IE - Irlanda 289
CA - Canada 258
TR - Turchia 249
KR - Corea 187
ID - Indonesia 152
UA - Ucraina 150
JP - Giappone 133
CI - Costa d'Avorio 95
BE - Belgio 70
ES - Italia 69
EU - Europa 67
AU - Australia 62
PL - Polonia 60
PH - Filippine 57
MX - Messico 56
CH - Svizzera 50
ZA - Sudafrica 50
AR - Argentina 47
AT - Austria 41
CO - Colombia 41
IQ - Iraq 36
IR - Iran 36
CL - Cile 35
PK - Pakistan 33
EC - Ecuador 29
TH - Thailandia 27
TW - Taiwan 26
UZ - Uzbekistan 26
GR - Grecia 24
DK - Danimarca 23
SA - Arabia Saudita 23
KE - Kenya 21
PT - Portogallo 21
MY - Malesia 19
RO - Romania 16
VE - Venezuela 16
ET - Etiopia 15
MA - Marocco 14
CZ - Repubblica Ceca 13
EG - Egitto 13
NO - Norvegia 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
JO - Giordania 11
PY - Paraguay 11
NZ - Nuova Zelanda 10
PE - Perù 10
UY - Uruguay 9
AZ - Azerbaigian 8
LB - Libano 8
LU - Lussemburgo 8
NP - Nepal 8
JM - Giamaica 7
LT - Lituania 7
SC - Seychelles 7
AL - Albania 6
KZ - Kazakistan 6
MZ - Mozambico 6
OM - Oman 6
PR - Porto Rico 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
BW - Botswana 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
MM - Myanmar 5
AM - Armenia 4
BY - Bielorussia 4
CM - Camerun 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
QA - Qatar 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GH - Ghana 3
GT - Guatemala 3
HR - Croazia 3
KW - Kuwait 3
LV - Lettonia 3
Totale 27.763
Salva come PNG Salva come JPEG
Città #
Southend 1.688
Singapore 1.351
Dallas 1.151
Ashburn 967
Hong Kong 720
Chandler 633
Milan 610
San Jose 557
Beijing 439
Council Bluffs 339
Los Angeles 322
Dublin 285
Seattle 244
Ann Arbor 240
Fairfield 236
Santa Clara 233
Princeton 230
Wilmington 219
Ho Chi Minh City 211
Frankfurt am Main 183
New York 174
Helsinki 173
Lauterbourg 170
Hefei 159
Hanoi 154
Boardman 152
Hanover 145
Houston 145
Guangzhou 134
Toronto 131
Woodbridge 129
Buffalo 124
Moscow 122
Bengaluru 112
Istanbul 109
Rome 106
Dearborn 103
Cambridge 98
Jakarta 98
Abidjan 95
Shanghai 92
The Dalles 86
Munich 84
Seoul 84
Tokyo 82
Nanjing 81
Columbus 80
Jacksonville 78
São Paulo 73
Redmond 72
Des Moines 71
Mountain View 71
Tianjin 63
Chicago 59
Phoenix 51
Brussels 50
Nuremberg 46
Berlin 44
Cangzhou 41
Bodio Lomnago 40
Shenzhen 40
Amsterdam 38
Montreal 37
Sakarya 37
London 36
Somerville 36
Turku 36
Da Nang 35
Orem 34
Shenyang 34
Warsaw 34
Andover 33
Boston 32
Mumbai 32
Redwood City 32
San Diego 32
Turin 31
Jinan 30
Bogotá 29
Haiphong 27
Atlanta 26
Chennai 26
Ottawa 26
Nanchang 25
Piscataway 25
Sunnyvale 25
Lappeenranta 24
Naples 24
Washington 24
Fremont 23
Fuzhou 23
Hangzhou 23
Stockholm 23
Changsha 22
Serra 22
Dong Ket 21
Florence 21
Vienna 21
Bühl 20
Denver 20
Totale 15.978
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 1.116
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 661
Prevalenza ed epidemiologia molecolare di HTLV-1 in immigrati HIV positivi e in soggetti viventi in Perù e in Africa Occidentale 475
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 408
Description of a "Trans-Saharan" strain of human T-Lymphotropic virus type 1 in West Africa 390
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 357
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 349
Clinical features and outcomes of HIV patients with coronavirus disease 2019 344
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study 333
The human IL-7 receptor gene: Deletions, polymorphisms and mutations 330
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients : is it time to revise atazanavir dosages? 326
H3K4me3 Histone ChIP-Seq Analysis Reveals Molecular Mechanisms Responsible for Neutrophil Dysfunction in HIV-Infected Individuals 324
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection 323
Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau 322
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 319
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology 312
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 304
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study 302
Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients 290
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 284
Abacavir-induced liver toxicity 281
Genomic characterisation and phylogenetic analysis of SARS-COV-2 in Italy 281
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 273
A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients 271
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 268
Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection 265
[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity 260
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy 256
A point mutation affecting an SP1 binding site in the promoter of ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria 251
Remitting infections due to community-acquired Panton–Valentine leukocidin-producing Staphylococcus aureus in the Milan area 243
Clinical and genetic determinants of nevirapine plasma trough concentration 239
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity 239
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events 235
Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival : a cohort study 234
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages 228
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 225
Comparing optical coherence tomography findings in different aetiologies of infectious necrotising retinitis 221
A 40 colors spectral panel to decipher human NK cell involvement in the establishment of NeuroCOVID-19 214
Polymorphisms in genes involved in lipid metabolism and apoptosis differently influence atrophy and fat accumulation in HIV related lipodystrophy 209
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection 209
Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin 208
Tuberculous meningitis in a patient with acute human immunodeficiency virus infection 205
Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein 203
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients 202
Peripheral blood pre-erythroidal cells in HIV-1 infection 201
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers 198
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 197
Increased CD36 expression in vertically human immunodeficiency virus-infected children unrelated to antiretroviral therapy 197
Correlation between inner retinal layer thickness and cognitive function in HIV: New insights from an exploratory study 197
Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats 195
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 195
Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity 193
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 193
Expression of Interleukin-15 and Interleukin-15Rα in Monocytes of HIV Type 1-Infected Patients with Different Courses of Disease Progression 192
Long-Term Effects of SARS-CoV-2 Infection in Hospitalized Children: Findings from an Italian Single-Center Study 191
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms 190
Peripheral blood T regulatory cells and TH17 cells and their genes expression profile in HIV-1 infected patients and healthy controls 189
Analysis of Retinochoroidal Vasculature in Human Immunodeficiency Virus Infection Using Spectral-Domain OCT Angiography 187
Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature 186
Tubercular gluteus abscesses: a return to the early 20th century or a consequence of new, unprecedented behaviors? 185
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors 182
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 181
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 180
C1 esterase inhibitor and the kinin-kallikrein system in COVID-19 176
Definition of the Immune Parameters Related to COVID-19 Severity 176
Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation : US evaluation 175
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History 174
C-13-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients 173
Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project 172
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 171
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 169
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease 168
Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy 167
Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors 167
Choroidal Thickness in Patients Diagnosed with Human Immunodeficiency Virus Infection : Results from Two Populations of Different Ethnicities 166
Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease 165
Analyses of Pre-erythroid cells in peripheral blood of patients with different progression of HIV infection 164
Darunavir does not prevent SARS-CoV-2 infection in HIV patients 163
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients 161
Operationalisation of post-COVID condition case definition in a comprehensive research protocol 157
Choroidal Thickness in Patients Diagnosed with Human Immunodeficiency Virus Infection: Results from Two Populations of Different Ethnicities : Response to Chay et al.’s Letter 156
mRNA expression profile of adipose tissue in HIV-1 positive subjects with art-related lipoatrophy 154
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes 153
Impaired mitochondrial function in HIV-1 infected patients during antiretroviral treatment detected in vivo with a 13C-methionine breath test 152
Maintenance of naive and Th1 CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens 151
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 150
Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? 150
Avascular necrosis of the femoral head in a HIV-1 infected patient receiving lopinavir/ritonavir. 148
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection 147
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 145
Higher expression of Adiponectin Q and lower expression of enhancer binding protein alpha in adipose tissue characterize HIV-1 infected patients with lypodystrophy 142
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy 142
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination 142
Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect? 140
In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection 138
The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir 136
Orlistat: weight lost at cost of HIV rebound 134
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era 133
Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine 133
Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients 133
Totale 22.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021395 0 0 0 0 0 0 0 0 0 0 258 137
2021/20222.185 124 140 155 129 174 154 175 168 280 183 143 360
2022/20232.428 274 264 224 265 239 421 87 139 262 48 135 70
2023/20242.017 80 183 138 155 393 213 154 123 80 94 188 216
2024/20254.424 159 424 105 357 368 204 227 438 289 423 498 932
2025/202611.615 921 1.139 1.515 1.037 1.101 779 1.399 645 1.230 811 1.038 0
Totale 28.920